Last reviewed · How we verify
Pivmecillinamhydrochlorid
At a glance
| Generic name | Pivmecillinamhydrochlorid |
|---|---|
| Also known as | Selexid |
| Sponsor | Oslo University Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pivmecillinamhydrochlorid CI brief — competitive landscape report
- Pivmecillinamhydrochlorid updates RSS · CI watch RSS
- Oslo University Hospital portfolio CI